Enzon Pharmaceuticals Valuation
| ENZNDelisted Stock | USD 0.20 0.01 5.26% |
Enzon Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Enzon Pharmaceuticals from reviewing the firm fundamentals such as Operating Margin of (36.28) %, shares owned by insiders of 10.70 %, and Shares Outstanding of 74.21 M as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Enzon Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Enzon Pharmaceuticals is based on 3 months time horizon. Increasing Enzon Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Enzon otc stock is determined by what a typical buyer is willing to pay for full or partial control of Enzon Pharmaceuticals. Since Enzon Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enzon OTC Stock. However, Enzon Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.16 | Hype 0.2 | Naive 0.2 |
The intrinsic value of Enzon Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enzon Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enzon Pharmaceuticals helps investors to forecast how Enzon otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enzon Pharmaceuticals more accurately as focusing exclusively on Enzon Pharmaceuticals' fundamentals will not take into account other important factors: Enzon Pharmaceuticals Total Value Analysis
Enzon Pharmaceuticals is currently forecasted to have valuation of 17.63 M with market capitalization of 19.72 M, debt of 0, and cash on hands of 46.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Enzon Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.63 M | 19.72 M | 0 | 46.79 M |
Enzon Pharmaceuticals Investor Information
About 49.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.04. Enzon Pharmaceuticals last dividend was issued on the 30th of September 2019. The entity had 1:1 split on the 29th of September 2017. Based on the key indicators related to Enzon Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Enzon Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Enzon Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Enzon Pharmaceuticals has an asset utilization ratio of 1.47 percent. This suggests that the OTC Stock is making $0.0147 for each dollar of assets. An increasing asset utilization means that Enzon Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Enzon Pharmaceuticals Ownership Allocation
Enzon Pharmaceuticals holds a total of 74.21 Million outstanding shares. 30% of Enzon Pharmaceuticals outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Enzon Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 701 K. Net Loss for the year was (469 K) with profit before overhead, payroll, taxes, and interest of 701 K.About Enzon Pharmaceuticals Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Enzon Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Enzon Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Enzon Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Enzon Pharmaceuticals's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enzon Pharmaceuticals. We calculate exposure to Enzon Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Enzon Pharmaceuticals's related companies.Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company was founded in 1981 and is headquartered in Cranford, New Jersey. Enzon Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Enzon Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Enzon Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Enzon Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Enzon Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Enzon Pharmaceuticals' revenue streams: Identify Enzon Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Enzon Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Enzon Pharmaceuticals' growth potential: Evaluate Enzon Pharmaceuticals' management, business model, and growth potential.
- Determine Enzon Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Enzon Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Enzon Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 74.2 M | |
| Retained Earnings | -71.9 M | |
| Forward Annual Dividend Rate | 0.12 | |
| Shares Float | 30.2 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |